Literature DB >> 19920201

Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Zheming Lu1, Lei Zhou, Patrick Killela, Ahmed B Rasheed, Chunhui Di, William E Poe, Roger E McLendon, Darell D Bigner, Christopher Nicchitta, Hai Yan.   

Abstract

Glioblastoma multiforme is the most prevalent type of adult brain tumor and one of the deadliest tumors known to mankind. The genetic understanding of glioblastoma multiforme is, however, limited, and the molecular mechanisms that facilitate glioblastoma multiforme cell survival and growth within the tumor microenvironment are largely unknown. We applied digital karyotyping and single nucleotide polymorphism arrays to screen for copy-number changes in glioblastoma multiforme samples and found that the most frequently amplified region is at chromosome 7p11.2. The high resolution of digital karyotyping and single nucleotide polymorphism arrays permits the precise delineation of amplicon boundaries and has enabled identification of the minimal region of amplification at chromosome 7p11.2, which contains two genes, EGFR and SEC61gamma. SEC61gamma encodes a subunit of a heterotrimeric protein channel located in the endoplasmic reticulum (ER). In addition to its high frequency of gene amplification in glioblastoma multiforme, SEC61gamma is also remarkably overexpressed in 77% of glioblastoma multiforme but not in lower-grade gliomas. The small interfering RNA-mediated knockdown of SEC61gamma expression in tumor cells led to growth suppression and apoptosis. Furthermore, we showed that pharmacologic ER stress agents induce SEC61gamma expression in glioblastoma multiforme cells. Together, these results indicate that aberrant expression of SEC61gamma serves significant roles in glioblastoma multiforme cell survival likely via a mechanism that is involved in the cytoprotective ER stress-adaptive response to the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920201      PMCID: PMC2789175          DOI: 10.1158/0008-5472.CAN-09-2775

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element.

Authors:  N M Mazure; E Y Chen; K R Laderoute; A J Giaccia
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

2.  Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences.

Authors:  X Y Wang; D I Smith; L Frederick; C D James
Journal:  Oncogene       Date:  1998-01-15       Impact factor: 9.867

3.  Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas.

Authors:  K Akiyama; N Kanda; M Yamada; K Tadokoro; T Matsunaga; Y Nishi
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

4.  High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.

Authors:  J L Reiter; G M Brodeur
Journal:  Genomics       Date:  1996-02-15       Impact factor: 5.736

5.  Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression.

Authors:  J W Brewer; L M Hendershot; C J Sherr; J A Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers.

Authors:  A G Elkahloun; M Bittner; K Hoskins; R Gemmill; P S Meltzer
Journal:  Genes Chromosomes Cancer       Date:  1996-12       Impact factor: 5.006

7.  The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.

Authors:  L C Amler; J Schürmann; M Schwab
Journal:  Genes Chromosomes Cancer       Date:  1996-02       Impact factor: 5.006

8.  High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.

Authors:  J L Hiemstra; S S Schneider; G M Brodeur
Journal:  Prog Clin Biol Res       Date:  1994

9.  Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults.

Authors:  M C Mostert; A J Verkerk; M van de Pol; J Heighway; P Marynen; C Rosenberg; A G van Kessel; J van Echten; B de Jong; J W Oosterhuis; L H Looijenga
Journal:  Oncogene       Date:  1998-05       Impact factor: 9.867

10.  The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment.

Authors:  J J Greenfield; S High
Journal:  J Cell Sci       Date:  1999-05       Impact factor: 5.285

View more
  30 in total

1.  The deadly connection between endoplasmic reticulum, Ca2+, protein synthesis, and the endoplasmic reticulum stress response in malignant glioma cells.

Authors:  Guyla G Johnson; Misti C White; Jian-He Wu; Matthew Vallejo; Maurizio Grimaldi
Journal:  Neuro Oncol       Date:  2014-02-24       Impact factor: 12.300

Review 2.  Components and Mechanisms of Import, Modification, Folding, and Assembly of Immunoglobulins in the Endoplasmic Reticulum.

Authors:  Richard Zimmermann
Journal:  J Clin Immunol       Date:  2016-02-29       Impact factor: 8.317

3.  Aberrant expression of Sec61α in esophageal cancers.

Authors:  Kai Bachmann; Maximillian Bockhorn; Oliver Mann; Florian Gebauer; Marco Blessmann; Jakob Robert Izbicki; Katharina Grupp
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-13       Impact factor: 4.553

4.  Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.

Authors:  Christopher G Duncan; Patrick J Killela; Cathy A Payne; Benjamin Lampson; William C Chen; Jeff Liu; David Solomon; Todd Waldman; Aaron J Towers; Simon G Gregory; Kerrie L McDonald; Roger E McLendon; Darell D Bigner; Hai Yan
Journal:  Oncotarget       Date:  2010-08

5.  Relationships linking amplification level to gene over-expression in gliomas.

Authors:  Nicolas Vogt; Anne Gibaud; Anna Almeida; Isabelle Ourliac-Garnier; Michelle Debatisse; Bernard Malfoy
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

6.  DawnRank: discovering personalized driver genes in cancer.

Authors:  Jack P Hou; Jian Ma
Journal:  Genome Med       Date:  2014-07-31       Impact factor: 11.117

7.  Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.

Authors:  Daniel Hagerstrand; Alexander Tong; Steven E Schumacher; Nina Ilic; Rhine R Shen; Hiu Wing Cheung; Francisca Vazquez; Yashaswi Shrestha; So Young Kim; Andrew O Giacomelli; Joseph Rosenbluh; Anna C Schinzel; Nicole A Spardy; David A Barbie; Craig H Mermel; Barbara A Weir; Levi A Garraway; Pablo Tamayo; Jill P Mesirov; Rameen Beroukhim; William C Hahn
Journal:  Cancer Discov       Date:  2013-06-13       Impact factor: 39.397

8.  SEC61G plays an oncogenic role in hepatocellular carcinoma cells.

Authors:  Huijie Gao; Weibo Niu; Zhaobin He; Chao Gao; Cheng Peng; Jun Niu
Journal:  Cell Cycle       Date:  2020-11-10       Impact factor: 4.534

Review 9.  Classification of subpopulations of cells within human primary brain tumors by single cell gene expression profiling.

Authors:  Elin Möllerström; Bertil Rydenhag; Daniel Andersson; Isabell Lebkuechner; Till B Puschmann; Meng Chen; Ulrika Wilhelmsson; Anders Ståhlberg; Kristina Malmgren; Milos Pekny
Journal:  Neurochem Res       Date:  2014-09-24       Impact factor: 3.996

10.  Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.

Authors:  Sabine M G van der Sanden; Weilin Wu; Naomi Dybdahl-Sissoko; William C Weldon; Paula Brooks; Jason O'Donnell; Les P Jones; Cedric Brown; S Mark Tompkins; M Steven Oberste; Jon Karpilow; Ralph A Tripp
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.